Cost-Effective and Robust Continuous Biotech Bio-Based Processes
    Cost-Effective and Robust Continuous Biotech Bio-Based Processes
    Grant

    Cost-Effective and Robust Continuous Biotech Bio-Based Processes

    Apply by Sep 18, 2025
    Application Closed

    About

    The European Commission is offering €14 million in funding for projects that aim to revolutionize biotech processes by transitioning to continuous biotech bio-based processes, contributing to EU initiatives on sustainability, circular economy, and industrial competitiveness.

    Benefits

    • πŸ’°Financial Support
      Funding of €14 million for projects
    • 🌍EU Initiatives Contribution
      Contribution to EU initiatives on Biotech and Biomanufacturing, Circular Economy, Zero Pollution, and Industrial Strategy
    • πŸ“ˆExpected Outcomes
      Expected outcomes include increased scale-up potential, productivity, and sustainability of biotech processes.

    Eligibility Criteria

    • Legal entities from EU Member States, associated countries, and certain international organizations are eligible to participate
    • Legal entities must meet conditions laid out in the Horizon Europe Regulation
    • Entities eligible for funding must be established in specific countries listed in the call.

    Target Region

    Global

    Target Sector

    Biotechnology

    European Commission